Zobrazeno 1 - 10
of 167
pro vyhledávání: '"ALFREDO MUSSI"'
Autor:
Laura Boldrini, Mirella Giordano, Cristina Niccoli, Franca Melfi, Marco Lucchi, Alfredo Mussi, Gabriella Fontanini
Publikováno v:
Cancer Cell International, Vol 17, Iss 1, Pp 1-7 (2017)
Abstract Background MiRNAs are vital in functioning as either oncogenes or tumor suppressors in the cell cycle. Target transcripts for immune checkpoint molecules such as PD-1/PD-L1 and (programmed cell death-1/its ligand and cytotoxic T-lymphocyte a
Externí odkaz:
https://doaj.org/article/c8c0c0ebf9b148f8aed2901c2510500a
Autor:
Fabio Coppedè, Roberta Ricciardi, Maria Denaro, Anna De Rosa, Carlo Provenzano, Emanuela Bartoccioni, Angelo Baggiani, Marco Lucchi, Alfredo Mussi, Lucia Migliore
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e80846 (2013)
Increasing evidence suggests a contribution of epigenetic processes in promoting cancer and autoimmunity. Myasthenia gravis (MG) is an autoimmune disease mediated, in approximately 80% of the patients, by antibodies against the nicotinic acetylcholin
Externí odkaz:
https://doaj.org/article/c74fa9a3f8ff45de97d117f7f3b6b7a5
Autor:
Marco Lucchi, Mirella Giordano, Franca Melfi, Gabriella Fontanini, Alfredo Mussi, Cristina Niccoli, Laura Boldrini
Publikováno v:
Cancer Cell International, Vol 17, Iss 1, Pp 1-7 (2017)
Cancer Cell International
Cancer Cell International
Background MiRNAs are vital in functioning as either oncogenes or tumor suppressors in the cell cycle. Target transcripts for immune checkpoint molecules such as PD-1/PD-L1 and (programmed cell death-1/its ligand and cytotoxic T-lymphocyte antigen 4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f523c13172df8dddeaacc2e50555bef
http://link.springer.com/article/10.1186/s12935-017-0474-y
http://link.springer.com/article/10.1186/s12935-017-0474-y
Autor:
Marco Lucchi, Alfredo Mussi, Antonio Chella, Nicolino Ambrosino, Alfonso Cristaudo, Elena Donadio, S Simonini, Rudy Foddis, Laura Giusti, Letizia Marconi, Maria Rosa Mazzoni, Alessandra Bonotti, E Pantani
Publikováno v:
The International Journal of Biological Markers. 32:126-131
Introduction Malignant pleural mesothelioma (MPM) is a relatively rare tumor, with the epithelioid type occurring more frequently. Several biomarkers have been suggested for screening and early diagnosis of MPM. Currently, high levels of soluble meso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab2d8d60d5d16c963a8f04b033314253
https://doi.org/10.5301/jbm.5000229
https://doi.org/10.5301/jbm.5000229
Autor:
Franca Melfi, Gabrilele Massimetti, Roberto Cioni, Marcello Carlo Ambrogi, Olivia Fanucchi, Carla Cappelli, Vittorio Aprile, Alfredo Mussi
Publikováno v:
Interactive CardioVascular and Thoracic Surgery. 23:57-64
OBJECTIVES: Surgical resection of pulmonary metastases is considered as a therapeutic procedure in selected cases. However, many patients are unable to tolerate surgical intervention due to comorbidities and/or poor pulmonary reserve, also related to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48ae13a849579c5b11fe477eefe7f690
https://doi.org/10.1093/icvts/ivw089
https://doi.org/10.1093/icvts/ivw089
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 154:e11-e13
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e207aa28d37519a8d3e2f586354983d
https://doi.org/10.1016/j.jtcvs.2017.03.036
https://doi.org/10.1016/j.jtcvs.2017.03.036
Autor:
Giordano, M., Laura Boldrini, Servadio, A., Niccoli, C., franca melfi, MARCO LUCCHI, ALFREDO MUSSI, Gabriella Fontanini
Publikováno v:
Università di Pisa-IRIS
Lung cancer is the leading cause of cancer-related mortality, and approximately 80% of cases are non-small cell lung cancer (NSCLC). Recently, the incidence of NSCLC has been quickly increasing, while the age of patients at diagnosis is decreasing. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f99f9568d2969d2fbe07555b5f5538b5
https://europepmc.org/articles/PMC5883130/
https://europepmc.org/articles/PMC5883130/
Malignant pleural mesothelioma (MPM) is still considered a relatively rare tumour, although Europe is at the peak of an epidemic of malignant pleural mesothelioma and the burden of disease is likely to continue rising in the large areas of the world
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80ecf33f04f4161eb76e4f0d248698b7
http://hdl.handle.net/11568/916662
http://hdl.handle.net/11568/916662
Surgery is one of the steps of multimodality approach for the treatment of MPM. Due to anatomical features, microscopically radical (R0) resection is never possible and a Macroscopic Complete Resection (R1) is considered the target for mesothelioma s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f689564b29f9485fdf15819a74cb446
https://europepmc.org/articles/PMC5830563/
https://europepmc.org/articles/PMC5830563/
Autor:
Roberta Ricciardi, Melania Guida, Marco Lucchi, Alfredo Mussi, Angela Lopomo, Michelangelo Maestri, Franca Melfi, Fabio Coppedè, Lucia Migliore, Anna De Rosa
Background Myasthenia Gravis (MG) is caused, in approximately 80% of the patients, by autoantibodies against the nicotinic acetylcholine receptor (AChR). The disease is often associated with pathological changes of the thymus: thymic epithelial tumou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8595415f379817eb35499cd85bc4d422
http://hdl.handle.net/11568/888852
http://hdl.handle.net/11568/888852